RELIEF-DPN-1 clinical trial : Lexicon begins patient dosing with LX9211

RELIEF-DPN-1 clinical trial : Lexicon Pharmaceuticals has started patient dosing in a phase 2 trial of LX9211 for the treatment of diabetic peripheral neuropathic pain. ... Read More